LIGACHEM
Live / Registered — Registered (as of 26 Aug 2025)
What this means for you
Registered since 26 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79408203
- Registration number
- 7910368
- Mark type
- Design + words
- Filed
- 06 Aug 2024
- Published for opposition
- 10 Jun 2025
- Registered
- 26 Aug 2025
- Attorney of record
- Richard Y. Kim
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; food supplements; vitamin preparations; crude medicines for treating cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; nutraceuticals for use as a dietary supplement; biological preparations for medical use for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; chemical preparations for medical use for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; syrups for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medicated lozenges for pharmaceutical purposes; capsules sold empty for pharmaceuticals; chemico-pharmaceutical preparations for pharmaceutical or medical purposes, namely, for cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; antibodies for medical purposes; medical antibodies, especially antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; pharmaceutical compositions for use in treatment and prevention of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; plant extracts, other than essential oils, for medicinal purposes; pharmaceutical preparations for cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets; pharmaceutical preparations for the treatment and prevention of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; antibiotics; anti-cancer preparations; mixed vitamin preparations; chemotherapeutics; pharmaceutical preparations for the treatment of rare cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases
Owner
Prosecution history
- 02 Apr 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 30 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 15 Mar 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 15 Mar 2026 — FINAL DISPOSITION PROCESSED
- 26 Nov 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Apr 2025 — REFUSAL PROCESSED BY IB
- 08 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE